HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ya-Huei Kuo Selected Research

Ya-Huei Kuo Research Topics

Disease

17Leukemia
02/2024 - 04/2005
16Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2024 - 01/2006
9Neoplasms (Cancer)
02/2024 - 05/2002
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2024 - 05/2016
2Myeloid Leukemia (Leukemia, Myelocytic)
05/2016 - 04/2009
2Neuroblastoma
06/2003 - 10/2002
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2023
1Disease Progression
11/2023
1Heart Diseases (Heart Disease)
03/2022
1Colonic Neoplasms (Colon Cancer)
10/2020
1Necrobiotic Disorders (Necrobiosis)
01/2020
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
01/2018
1Chromosome Aberrations (Chromosome Abnormalities)
01/2016
1Myeloproliferative Disorders (Myeloproliferative Disorder)
07/2012

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
11/2023 - 06/2003
5Tyrosine Kinase InhibitorsIBA
02/2024 - 10/2014
4Peptides (Polypeptides)IBA
01/2020 - 05/2002
3MicroRNAs (MicroRNA)IBA
01/2022 - 01/2021
3STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
03/2016 - 01/2014
3Core Binding Factors (Core-Binding Factor)IBA
04/2009 - 04/2005
3Oncogene Proteins (Oncogene Protein)IBA
02/2008 - 01/2006
3pro-insulin-like growth factor IIBA
06/2003 - 05/2002
2Biomarkers (Surrogate Marker)IBA
03/2024 - 11/2023
2Arginine (L-Arginine)FDA Link
02/2024 - 01/2019
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2022 - 01/2021
2Phosphotransferases (Kinase)IBA
01/2019 - 09/2013
2Sirtuin 1IBA
01/2018 - 10/2014
1Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
02/2024
1Interferon Type IIBA
02/2024
1ProteomeIBA
11/2023
1CalcineurinIBA
03/2022
1N-propionylprocainamideIBA
03/2022
1Atrial Natriuretic Factor (ANF)IBA
03/2022
1Messenger RNA (mRNA)IBA
03/2022
1SAM Domain and HD Domain-Containing Protein 1IBA
01/2022
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2022
1HydrolasesIBA
01/2022
1triphosphoric acid (triphosphate)IBA
01/2022
1nelarabine (506U78)FDA Link
01/2022
1Guanosine Triphosphate (GTP)IBA
10/2020
1(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA
10/2020
1Ribosomal RNAIBA
10/2020
1Cadherins (E-Cadherin)IBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1PNC-27IBA
01/2020
1tyrosine receptor (receptor, tyrosine)IBA
01/2019
1Protein Isoforms (Isoforms)IBA
05/2016
1Transcription Factors (Transcription Factor)IBA
03/2016
1Telomerase (Telomerase Reverse Transcriptase)IBA
12/2014
1OligonucleotidesIBA
01/2014
1Small Interfering RNA (siRNA)IBA
01/2014
1Neoplasm Antigens (Tumor Antigens)IBA
01/2014
1Therapeutic UsesIBA
01/2014
1Toll-Like Receptor 9IBA
01/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
09/2013
1src-Family KinasesIBA
09/2013
1Dasatinib (BMS 354825)FDA Link
09/2013
1Thrombopoietin (c-mpl Ligand)IBA
07/2012
1CytokinesIBA
07/2012
1LigandsIBA
07/2012
14,5,6,7- tetrahydroisoxazolo(4,5- c)pyridin- 3- ol (THPO)IBA
07/2012
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
04/2009
1Core Binding Factor beta SubunitIBA
12/2006
1CBFbeta-MYH11 fusion proteinIBA
01/2006
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2002

Therapy/Procedure

4Drug Therapy (Chemotherapy)
10/2021 - 09/2013
3Therapeutics
02/2024 - 01/2018
1Injections
01/2014
1Transplantation
04/2009